definiens: shall mean the earliest to occur of ( i ) twelve ( 12 ) months from the enrollment of the first patient in the first Phase 3 clinical trial of A-002 ; ( ii ) Ithe e"rollnll!llt of 1.500 patients in such tria / l ; ( iii ) Isu.fpension . termination or completioll of the Iria / l ; ( iv ) Itl.e completion of a ... trategic licensing transaction HlI.id, yield " paymellls to tile Comp(my of ( .t least $ 25 millionl ; or ( v ) lallY transaction llr .series of related trtllu'actions to whic, hiC/. ill excess offifty percent ( 50 % ) of the Company 's voting ptlHler is Irall.sferred, Hlhether by melms of merger, pllblic offerings . recapitalizatiOl ' . a.<;set .sale or oIlier .similar IranstlC : tiOl ' . provided t"al ill ead . of ( iv ) IIIUI ( v ) tI.at the Company has initiotelltl.e fir.st Phase 3 C / iniclIltr;t.1 of A-002 prior to slIch date )